Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.14
+0.14 (2.00%)
Jun 27, 2025, 4:00 PM - Market closed
Journey Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | -8.3 | -14.67 | -3.85 | -29.63 | -43.99 | 5.28 | Upgrade
|
Depreciation & Amortization | 3.67 | 3.42 | 3.77 | 4.37 | 2.56 | 1.52 | Upgrade
|
Other Amortization | 0.35 | 0.31 | 0.36 | 0.06 | 2.57 | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 3.14 | - | 13.82 | - | Upgrade
|
Stock-Based Compensation | 6.02 | 6.1 | 2.61 | 4.43 | 2.47 | 0.15 | Upgrade
|
Provision & Write-off of Bad Debts | 0.71 | 0.52 | 0.44 | 0.28 | 0.05 | 0.05 | Upgrade
|
Other Operating Activities | -1.03 | -1.03 | 0.44 | 0.77 | 5.64 | 0.36 | Upgrade
|
Change in Accounts Receivable | -8.93 | 4.48 | 12.55 | -5.38 | 0.77 | -5.02 | Upgrade
|
Change in Inventory | -1.92 | -4.23 | 3.95 | 1.74 | -8.46 | -0.55 | Upgrade
|
Change in Accounts Payable | -0.94 | -2.1 | -18.42 | 14.34 | 20.39 | -0.15 | Upgrade
|
Change in Income Taxes | 0.02 | 0.01 | 0.02 | 0.03 | -0.09 | 2.19 | Upgrade
|
Change in Other Net Operating Assets | 3.42 | -1.92 | 0.24 | -4.55 | 2.1 | 1.3 | Upgrade
|
Operating Cash Flow | -6.94 | -9.13 | 5.24 | -13.53 | -2.18 | 5.13 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | - | -43.09% | Upgrade
|
Sale (Purchase) of Intangibles | -15 | -15 | -5 | -20 | -10 | -1.2 | Upgrade
|
Investing Cash Flow | -15 | -15 | -5 | -20 | -10 | -1.2 | Upgrade
|
Short-Term Debt Issued | - | - | 28 | 5 | 7 | - | Upgrade
|
Long-Term Debt Issued | - | 10 | 15 | 19.76 | 9.54 | - | Upgrade
|
Total Debt Issued | 10 | 10 | 43 | 24.76 | 16.54 | - | Upgrade
|
Short-Term Debt Repaid | - | - | -30.95 | -2.86 | -6.19 | - | Upgrade
|
Long-Term Debt Repaid | - | -1.25 | -21 | -5 | -5.3 | -0.5 | Upgrade
|
Total Debt Repaid | -1.88 | -1.25 | -51.95 | -7.86 | -11.49 | -0.5 | Upgrade
|
Net Debt Issued (Repaid) | 8.13 | 8.75 | -8.95 | 16.9 | 5.05 | -0.5 | Upgrade
|
Issuance of Common Stock | 10.88 | 8.29 | 4.62 | 0.14 | 32.54 | 0.01 | Upgrade
|
Other Financing Activities | -0.05 | -0.05 | -0.47 | -0.59 | -3.55 | - | Upgrade
|
Financing Cash Flow | 18.95 | 16.99 | -4.8 | 16.46 | 53.02 | -0.49 | Upgrade
|
Net Cash Flow | -2.99 | -7.13 | -4.56 | -17.08 | 40.84 | 3.45 | Upgrade
|
Free Cash Flow | -6.94 | -9.13 | 5.24 | -13.53 | -2.18 | 5.13 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | -22.45% | Upgrade
|
Free Cash Flow Margin | -12.34% | -16.26% | 6.62% | -18.37% | -3.45% | 11.53% | Upgrade
|
Free Cash Flow Per Share | -0.33 | -0.45 | 0.29 | -0.77 | -0.21 | 0.47 | Upgrade
|
Cash Interest Paid | 2.56 | 2.01 | 1.13 | 0.99 | - | - | Upgrade
|
Cash Income Tax Paid | 0.13 | 0.13 | 0.18 | 0.17 | 0.16 | 0.11 | Upgrade
|
Levered Free Cash Flow | -18.74 | -18.57 | -4.79 | -24.51 | -4.25 | 1.05 | Upgrade
|
Unlevered Free Cash Flow | -17.19 | -17.19 | -4.09 | -23.31 | -2.43 | 1.49 | Upgrade
|
Change in Net Working Capital | 7.56 | 3.16 | 6.13 | -5.1 | -14.32 | 3.89 | Upgrade
|
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.